A seldomly discussed topic in connection with the development of oligonucleotide drugs is how these novel drugs will interact with other therapeutics. The Pharmaco-miR database (presented at OTS 2012; the poster is available here: PharmacomiR – The miRNA pharmacogenomics DB)…
Blog Archives
Poster on antimiR optimization at the OTS 2012 meeting
The following poster will be presented at the Oligonucleotide Therapeutics Society Annual Meeting 2012: Potency of oligonucleotides targeting microRNAs can be predicted from their sequence.
The transcriptome ‐ from functional RNAs to RNA drugs
We now (finally) have the program for the symposium on the 24th of August in the Lundbeckfond Auditorium, Copenhagen Biocenter. The symposium is arranged together with Center for non-coding RNA in Technology and Health and sponsored by the The Danish Council…
Bioinformatics tasks for antimiR drug discovery and development
I was recently asked about what the core tasks and competences are for bioinformatics in the discovery of microRNA targeted drugs. Based on my 5 years with bioinformatics at Santaris Pharma, I will give my opinion on what constitutes a…
Posted in miRNA, Oligoinformatics
Summer school on RNA biology and drugs
There is an exciting PhD course to take place from the 20th to the 24th of August in Copenhagen. The course will cover the following topics: parallel sequencing technologies, microRNA Biology and ‐targeting, protein‐RNA interactions, RNA structure and antisense oligonucleotide…